Effects of chronic haloperidol and clozapine treatment on AMPA and kainate receptor binding in rat brainSCHMITT, A; MAY, B; MÜLLER, B et al.Pharmacopsychiatry. 2003, Vol 36, Num 6, pp 292-296, issn 0176-3679, 5 p.Article

Effects of treatment with chromium picolinate on peripheral amino acid availability and brain monoamine function in the ratFRANKLIN, M; ODONTIADIS, J.Pharmacopsychiatry. 2003, Vol 36, Num 5, pp 176-180, issn 0176-3679, 5 p.Article

Efficacy and safety of venlafaxine ER vs. amitriptyline ER in patients with major depression of moderate severitySAUER, Heinrich; HUPPERTZ-HELMHOLD, Sabine; DIERKES, Wilfried et al.Pharmacopsychiatry. 2003, Vol 36, Num 5, pp 169-175, issn 0176-3679, 7 p.Article

Cytochrome P450 2D6 deficiency and its clinical relevance in a patient treated with risperidoneKÖHNKE, M. D; GRIESE, E.-U; STÖSSER, D et al.Pharmacopsychiatry. 2002, Vol 35, Num 3, pp 116-118, issn 0176-3679Article

Effects of anticholinergic drug withdrawal on memory, regional cerebral blood flow and extrapyramidal side effects in schizophrenic patientsMORI, K; YAMASHITA, H; NAGAO, M et al.Pharmacopsychiatry. 2002, Vol 35, Num 1, pp 6-11, issn 0176-3679Article

Heart-rate variability (HRV) in the ECG trace of routine EEGs: Fast monitoring for the anticholinergic effects of clozapine and olanzapine?ESCHWEILER, G. W; BARTELS, M; LÄNGLE, G et al.Pharmacopsychiatry. 2002, Vol 35, Num 3, pp 96-100, issn 0176-3679Article

Paroxetine-induced vaginal AnaesthesiaMICHAEL, A; ANDREWS, S.Pharmacopsychiatry. 2002, Vol 35, Num 4, pp 150-151, issn 0176-3679Article

Relationship between cortisol and serotonin metabolites and transporters in alcolholismHEINZ, A; JONES, D. W; BISSETTE, G et al.Pharmacopsychiatry. 2002, Vol 35, Num 4, pp 127-134, issn 0176-3679Article

Visual hallucinations induced by the combination of prolintane and diphenhydraminePAYA, B; GUISADO, J. A; VAZ, F. J et al.Pharmacopsychiatry. 2002, Vol 35, Num 1, pp 24-25, issn 0176-3679Article

Pharmacological treatment strategies of residential primary care providers in dementia diseases. Results of a representative survey in Western AustriaGURKA, P; BACHER, R; KEMMLER, G et al.Pharmacopsychiatry. 2002, Vol 35, Num 4, pp 144-149, issn 0176-3679Article

Successful treatment of Recurrent Brief Depression with reboxetine: A single case analysisPEZAWAS, L; STAMENKOVIC, M; ASCHAUER, N et al.Pharmacopsychiatry. 2002, Vol 35, Num 2, pp 75-76, issn 0176-3679Article

Effect of a low tryptophan diet on the prolactin responses to the 5-HT_2A agonist DOI in the ratFRANKLIN, M; COWEN, P. J.Pharmacopsychiatry. 2001, Vol 34, Num 4, pp 147-149, issn 0176-3679Article

Subclinical pancreatitis related to mirtazapine : A case reportSOMMER, M; DIETERICH, A; KRAUSE, C et al.Pharmacopsychiatry. 2001, Vol 34, Num 4, pp 158-159, issn 0176-3679Article

Posthallucinogen-like visual illusions (Palinopsia) with risperidone in a patient without previous hallucinogen exposure : Possible relation to serotonin 5HT2a receptor blockadeLAUTERBACH, E. C; ABDELHAMID, A; ANNANDALE, J. B et al.Pharmacopsychiatry. 2000, Vol 33, Num 1, pp 38-41, issn 0176-3679Article

Influence of methodology on outcomes of randomised clozapine trialsWAHLBECK, K; TUUNAINEN, A; GILBODY, S et al.Pharmacopsychiatry. 2000, Vol 33, Num 2, pp 54-59, issn 0176-3679Conference Paper

A possible case of lithium intoxication mimicking Creutzfeld-Jakob syndromeSLAMA, M; MASMOUDI, K; BLANCHARD, N et al.Pharmacopsychiatry. 2000, Vol 33, Num 4, pp 145-146, issn 0176-3679Article

Association of paroxetine with suicide attempt in obsessive-compulsive disorderGÖDER, R; FRIEGE, L; TRESKOV, V et al.Pharmacopsychiatry. 2000, Vol 33, Num 3, pp 116-117, issn 0176-3679Article

Word recognition memory before and after successful treatment of depressionDIETRICH, D. E; KLEINSCHMIDT, A; HAUSER, U et al.Pharmacopsychiatry. 2000, Vol 33, Num 6, pp 221-228, issn 0176-3679Article

Akathisia masked by hypokinesiaTUISKU, K; LAUERMA, H; HOLI, M. M et al.Pharmacopsychiatry. 2000, Vol 33, Num 4, pp 147-149, issn 0176-3679Article

Is the EEG helpful in diagnosing and monitoring lithium intoxication? A case report and review of the literatureGALLINAT, J; BOETSCH, T; PADBERG, F et al.Pharmacopsychiatry. 2000, Vol 33, Num 5, pp 169-173, issn 0176-3679Article

Diurnal variability of orofacial dyskinetic movementsBACA-GARCIA, E; STANILLA, J. K; BÜCHEL, C et al.Pharmacopsychiatry. 1999, Vol 32, Num 2, pp 73-75, issn 0176-3679Article

Treatment of alcohol withdrawal syndrome with gabapentinBONNET, U; BANGER, M; LEWEKE, F. M et al.Pharmacopsychiatry. 1999, Vol 32, Num 3, pp 107-109, issn 0176-3679Article

Clinical experience using adjunctive gabapentin in treatment-resistant bipolar mixed statesPERUGI, G; TONI, C; RUFFOLO, G et al.Pharmacopsychiatry. 1999, Vol 32, Num 4, pp 136-141, issn 0176-3679Article

Possible use of amantadine in depressionHUBER, T. J; DIETRICH, D. E; EMRICH, H. M et al.Pharmacopsychiatry. 1999, Vol 32, Num 2, pp 47-55, issn 0176-3679Article

The importance of new antidepressants in the treatment of anxiety/depressive disordersBOERNER, R. J; MÖLLER, H. J.Pharmacopsychiatry. 1999, Vol 32, Num 4, pp 119-126, issn 0176-3679Article